These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26885534)

  • 1. Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy.
    Ivanova EA; Orekhov AN
    J Immunol Res; 2016; 2016():4789279. PubMed ID: 26885534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of monocytes and macrophages.
    Mantovani A; Vecchi A; Allavena P
    Curr Opin Pharmacol; 2014 Aug; 17():38-44. PubMed ID: 25062123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL does not influence the polarization of human monocytes toward an alternative phenotype.
    Colin S; Fanchon M; Belloy L; Bochem AE; Copin C; Derudas B; Stroes ES; Hovingh GK; Kuivenhoven JA; Dallinga-Thie GM; Staels B; Chinetti-Gbaguidi G
    Int J Cardiol; 2014 Mar; 172(1):179-84. PubMed ID: 24456889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-mercaptopurine inhibits atherosclerosis in apolipoprotein e*3-leiden transgenic mice through atheroprotective actions on monocytes and macrophages.
    Pols TW; Bonta PI; Pires NM; Otermin I; Vos M; de Vries MR; van Eijk M; Roelofsen J; Havekes LM; Quax PH; van Kuilenburg AB; de Waard V; Pannekoek H; de Vries CJ
    Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1591-7. PubMed ID: 20413732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monocyte/macrophage as a therapeutic target in atherosclerosis.
    Saha P; Modarai B; Humphries J; Mattock K; Waltham M; Burnand KG; Smith A
    Curr Opin Pharmacol; 2009 Apr; 9(2):109-18. PubMed ID: 19230773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis.
    Bobryshev YV; Ivanova EA; Chistiakov DA; Nikiforov NG; Orekhov AN
    Biomed Res Int; 2016; 2016():9582430. PubMed ID: 27493969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage: A Key Therapeutic Target in Atherosclerosis?
    Taghizadeh E; Taheri F; Renani PG; Reiner Ž; Navashenaq JG; Sahebkar A
    Curr Pharm Des; 2019; 25(29):3165-3174. PubMed ID: 31470780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy.
    Orekhov AN; Sobenin IA; Gavrilin MA; Gratchev A; Kotyashova SY; Nikiforov NG; Kzhyshkowska J
    Curr Pharm Des; 2015; 21(9):1172-9. PubMed ID: 25312739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A glimpse on the phenomenon of macrophage polarization during atherosclerosis.
    Pello OM; Silvestre C; De Pizzol M; Andrés V
    Immunobiology; 2011 Nov; 216(11):1172-6. PubMed ID: 21802768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage polarization: the answer to the diet/inflammation conundrum?
    Dall'Asta M; Derlindati E; Ardigò D; Zavaroni I; Brighenti F; Del Rio D
    Nutr Metab Cardiovasc Dis; 2012 May; 22(5):387-92. PubMed ID: 22397874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macrophage activation in atherosclerosis. Message 2. Effects of factors on macrophage activation].
    Nikiforov NG; Elizova NV; Nikitina NA; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2016; 60(1):59-64. PubMed ID: 29215250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periodontitis-activated monocytes/macrophages cause aortic inflammation.
    Miyajima S; Naruse K; Kobayashi Y; Nakamura N; Nishikawa T; Adachi K; Suzuki Y; Kikuchi T; Mitani A; Mizutani M; Ohno N; Noguchi T; Matsubara T
    Sci Rep; 2014 Jun; 4():5171. PubMed ID: 24893991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages.
    Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G
    Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage phenotypes in atherosclerosis.
    Colin S; Chinetti-Gbaguidi G; Staels B
    Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].
    Nikiforov NG; Kornienko VY; Karagodin VP; Orekhov AN
    Patol Fiziol Eksp Ter; 2015; (3):128-31. PubMed ID: 26852607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vibrio cholerae porin OmpU mediates M1-polarization of macrophages/monocytes via TLR1/TLR2 activation.
    Khan J; Sharma PK; Mukhopadhaya A
    Immunobiology; 2015 Nov; 220(11):1199-209. PubMed ID: 26093918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of monocyte/macrophage polarisation by extracellular RNA.
    Cabrera-Fuentes HA; Lopez ML; McCurdy S; Fischer S; Meiler S; Baumer Y; Galuska SP; Preissner KT; Boisvert WA
    Thromb Haemost; 2015 Mar; 113(3):473-81. PubMed ID: 25589344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.
    Hance AJ; Douches S; Winchester RJ; Ferrans VJ; Crystal RG
    J Immunol; 1985 Jan; 134(1):284-92. PubMed ID: 3964815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-10 mediates the immunoregulatory response in conjugated linoleic acid-induced regression of atherosclerosis.
    McCarthy C; Duffy MM; Mooney D; James WG; Griffin MD; Fitzgerald DJ; Belton O
    FASEB J; 2013 Feb; 27(2):499-510. PubMed ID: 23070607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.